LBCA COO, Mason Mitchell-Daniels recently interviewed SAB Member, Dr. Rita Mukhtar about her latest ILC research, “Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.”  Dr. Mukhtar discusses the study which utilized the lobular breast cancer patient database at the University of California, San Francisco and isolated those patients that had received neoadjuvant pre-operative therapy and also had a breast MRI before surgery.

The study analyzed if the pre-operative tumor size reported matched up with the post-operative tumor pathology. Dr. Mukhtar noted the accuracy of these measurements are important because surgeons use them to plan the types of surgery they will perform and the discrepancy in tumor size pre and post surgery for ILC patients is often reported.

Watch the interview to learn more about Dr. Mukhtar’s thoughts on MRI tumor size reporting accuracy, questions that patients receiving neoadjuvant therapy can ask their doctors and what she sees as the next step in research.  To read the full study, click here.